title: Hyperthermic intraperitoneal chemotherapy: methodology and safety considerations.
abstract: Several methods of delivering hyperthermic intraperitoneal chemotherapy (HIPEC) during the course of cytoreductive surgery have been described, but no significant differences in treatment results have been found among them. HIPEC is a safe treatment for the patient and for healthcare workers involved in the procedure provided standard protective and environmental measures are used. This article describes the different techniques in use and the technology available for the administration of HIPEC. Also reviewed are the safety features that must be taken into consideration when performing this procedure. Recommended guidelines to prevent associated occupational hazards are provided.
authors.affiliation: Department of Surgical Oncology, MD Anderson Cancer Center, Madrid 28033, Spain. sgonzalez@mdanderson.es
authors.forename: Santiago
authors.initials: S
authors.lastname: González-Moreno
authors.forename: Luis
authors.initials: L
authors.lastname: González-Bayón
authors.forename: Gloria
authors.initials: G
authors.lastname: Ortega-Pérez
mesh_terms: D002277:Carcinoma / Q000188:drug therapy* / Q000601:surgery; D010478:Chemotherapy, Cancer, Regional Perfusion / Q000009:adverse effects* / Q000379:methods; D006801:Humans; D006979:Hyperthermia, Induced / Q000379:methods*; D007263:Infusions, Parenteral / Q000009:adverse effects* / Q000379:methods; D010534:Peritoneal Neoplasms / Q000188:drug therapy* / Q000601:surgery; D012449:Safety